REFERENCES
- Yu XJ, Dai WR, Xu Y. Survival outcome after stereotactic body radiation therapy and surgery for early stage non-small cell lung cancer: a meta-analysis. J Invest Surg. In press.
- Asamura H. Treatment of choice for stage I non-small cell lung cancer: surgery or radiotherapy? J Thorac Oncol. 2006;1(8):766–767. [https://doi.org/10.1016/S1556-0864(15)30403-2] PMID:17409957
- Videtic GM, Stephans KL. The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? Curr Oncol Rep. 2010;12(4):235–241. [https://doi.org/10.1007/s11912-010-0108-1] PMID:20446066
- Ricardi U, Badellino S, Filippi AR. Stereotactic radiotherapy for early stage non-small cell lung cancer. Radiat Oncol J. 2015;33(2):57–65.
- Chen H, Louie AV, Boldt RG et al. Quality of life after stereotactic ablative radiotherapy for early-stage lung cancer: a systematic review. Clin Lung Cancer. 2016;17(5):e141–e149. [https://doi.org/10.1016/j.cllc.2015.12.009] PMID:26157674
- Shirvani SM, Jiang J, Chang JY et al. Comparative effectiveness of 5 treatment strategies for early-stage non-small cell lung cancer in the elderly. Int J Radiat Oncol Biol Phys. 2012;84(5):1060–1070. [https://doi.org/10.1016/j.ijrobp.2012.07.2354] PMID:22975611
- Grills IS, Mangona VS, Welsh R et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28(6):928–935. [https://doi.org/10.1200/JCO.2009.25.0928] PMID:20065181
- Verstegen NE, Oosterhuis JW, Palma DA et al. Stage I-II non-small-cell lung cancer treated using either stereotactic ablative radiotherapy (SABR) or lobectomy by video-assisted thoracoscopic surgery (VATS): outcomes of a propensity score-matched analysis. Ann Oncol. 2013;24(6):1543–1548. [https://doi.org/10.1093/annonc/mdt026] PMID:23425947
- Crabtree T, Puri V, Timmerman R et al. Treatment of stage I lung cancer in high-risk and inoperable patients: comparison of prospective clinical trials using stereotactic body radiotherapy (RTOG 0236), sublobar resection (ACOSOG Z4032), and radiofrequency ablation (ACOSOG Z4033). J Thorac Cardiovasc Surg. 2013;145(3):692–699. [https://doi.org/10.1016/j.jtcvs.2012.10.038] PMID:23174176
- Onishi H, Shirato H, Nagata Y et al.. Stereotactic body radiotherapy (SBRT) for operable stage I non-small-cell lung cancer: can SBRT be comparable to surgery? Int J Radiat Oncol Biol Phys. 2011;81(5):1352–1358. [https://doi.org/10.1016/j.ijrobp.2009.07.1751] PMID:20638194
- Little AG, Rusch VW, Bonner JA et al. Patterns of surgical care of lung cancer patients. Ann Thorac Surg. 2005;80(6):2051–2056. [https://doi.org/10.1016/j.athoracsur.2005.06.071] PMID:16305843
- Chi A, Liao Z, Nguyen NP et al. Systemic review of the patterns of failure following stereotactic body radiation therapy in early-stage non-small-cell lung cancer: clinical implications. Radiother Oncol. 2010;94(1):1–11.[https://doi.org/10.1016/j.radonc.2009.12.008] PMID:20074823
- Park HK, Jeon K, Koh WJ et al. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT. Respirology 2010;15(8):1179–1184. [https://doi.org/10.1111/j.1440-1843.2010.01793.x] PMID:20573058
- Darling GE, Allen MS, Decker PA et al. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141(3):662–670. [https://doi.org/10.1016/j.jtcvs.2010.11.008] PMID:21335122